2025 MCM | After ESMO 2024: What Novel Therapies Are in Use and on Development for Pancreas and Biliary Cancers?

2025 MCM | After ESMO 2024: What Novel Therapies Are in Use and on Development for Pancreas and Biliary Cancers?

0% Complete

Course Content

This material is non-CME, no credits are available, and a certificate will not be provided upon completion.

Course Details

Duration
0.00 hour
Released
Jun 24, 2025
Last Review
Jun 24, 2025
Expires
Jun 24, 2026

Target Audience

Physicians

Nurses

Pharmacists

Physician Associates

Faculty & Disclosure

Faculty

Caio Max Rocha-Lima, MD, MS

Disclosure

Caio Max Rocha-Lima, MD, MS

Accreditation

NA